Sigyn Therapeutics Announces Virtual Presentation Today at the LD Micro Invitational Conference
08 juin 2021 06h00 HE
|
Sigyn Therapeutics, Inc.
The Presentation Will Occur at 5:30pm Eastern / 2:30pm Pacific Time SAN DIEGO, June 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical...
Sigyn Therapeutics Announces Corporate Update Webinar
18 mai 2021 08h30 HE
|
Sigyn Therapeutics, Inc.
The Event Occurs Friday, May 21st at 11am Eastern / 8am Pacific Time SAN DIEGO, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical...
Sigyn Therapeutics™ Discloses In-Vitro Viral Pathogen Study
21 avr. 2021 16h15 HE
|
Sigyn Therapeutics, Inc.
Sigyn Therapy™ demonstrates the ability to address viral pathogens, including SARS-CoV-2 (COVID-19) SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc....
The Closing Bell Featuring Sigyn Therapeutics
21 avr. 2021 09h30 HE
|
Sigyn Therapeutics, Inc.
The Interactive Videoconference Occurs Today at 4pm Eastern / 1pm Pacific Time SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a...
Sigyn Therapeutics Announces Force Wealth Roundtable Forum with Goldman Small Cap Research
16 mars 2021 08h30 HE
|
Sigyn Therapeutics, Inc.
The Event Occurs Tomorrow, March 17th at 12pm Eastern / 9am Pacific Time SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical...
Sigyn Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
08 mars 2021 15h08 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory...
Sigyn Therapeutics Announces Force Wealth Webinar Presentation on February 16th
11 févr. 2021 08h30 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory...
Sigyn Therapeutics Appoints Eric Lynam as Head of Clinical Affairs
26 janv. 2021 08h30 HE
|
Sigyn Therapeutics, Inc.
Mr. Lynam to Oversee Clinical Studies of Sigyn Therapy™ to Treat Life-Threatening Inflammatory Conditions SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc....
Recent Milestone Achievements of Sigyn Therapeutics Discussed During CEO Interview
19 janv. 2021 08h30 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), disclosed today that its Chairman and CEO Jim Joyce is featured in an interview with The...
Sigyn Therapeutics (SIGY) CEO Note: Overcoming the Limitations of Previous Cytokine Storm Treatment Strategies
12 janv. 2021 08h30 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. Dear...